Computational extraction of a neural molecular network through alternative splicing

BMC Research Notes

Hitoshi Suzuki⁴  Toshifumi Tsukahara²  Kozo Kawahara¹  Masahiro Takagi²  Mio Okazaki³  Huong Thi Thanh Phan²  Shafiul Alam² 

[1] World Fusion Co., Ltd, Chuo-ku, Tokyo 103-0013, Japan;School of Materials Science, Japan Advanced Institute of Science and Technology, Nomi, Ishikawa 923-1292, Japan;Department of Chemicals and Engineering, Miyakonojo National College of Technology, Miyakonojo, Miyazaki 885-0006, Japan;Center for Nano Materials and Technology, Japan Advanced Institute of Science and Technology, Nomi, Ishikawa 923-1292, Japan

关键词: Alternative splicing;    Neuronal differentiation;    Comprehensive analysis;   

Others  :  1091389
DOI  :  10.1186/1756-0500-7-934

 received in 2014-07-08, accepted in 2014-12-12,  发布年份 2014

【 摘 要 】

Background

Generally, the results of high throughput analyses contain information about gene expressions, and about exon expressions. Approximately 90% of primary protein-coding transcripts undergo alternative splicing in mammals. However, changes induced by alternative exons have not been properly analyzed for their impact on important molecular networks or their biological events. Even when alternative exons are identified, they are usually subjected to bioinformatics analysis in the same way as the gene ignoring the possibility of functionality change because of the alteration of domain caused by alternative exon. Here, we reveal an effective computational approach to explore an important molecular network based on potential changes of functionality induced by alternative exons obtained from our comprehensive analysis of neuronal cell differentiation.

Results

From our previously identified 262 differentially alternatively spliced exons during neuronal cell differentiations, we extracted 241 sets that changed the amino acid sequences between the alternatively spliced sequences. Conserved domain searches indicated that annotated domain(s) were changed in 128 sets. We obtained 49 genes whose terms overlapped between domain description and gene annotation. Thus, these 49 genes have alternatively differentially spliced in exons that affect their main functions. We performed pathway analysis using these 49 genes and identified the EGFR (epidermal growth factor receptor) and mTOR (mammalian target of rapamycin) signaling pathway as being involved frequently. Recent studies reported that the mTOR pathway is associated with neuronal cell differentiation, vindicating that our approach extracted an important molecular network successfully.

Conclusions

Effective informatics approaches for exons should be more complex than those for genes, because changes in alternative exons affect protein functions via alterations of amino acid sequences and functional domains. Our method extracted alterations of functional domains and identified key alternative splicing events. We identified the EGFR and mTOR signaling pathway as the most affected pathway. The mTOR pathway is important for neuronal differentiation, suggesting that this in silico extraction of alternative splicing networks is useful. This preliminary analysis indicated that automated analysis of the effects of alternative splicing would provide a rich source of biologically relevant information.

【 授权许可】

   
2014 Alam et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]International Human Genome Sequencing Consortium: Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
• [2]Graveley BR: Alternative splicing: increasing diversity in the proteomic world. Trends Genet 2001, 17:100-107.
• [3]Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB: Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
• [4]Park JW, Graveley BR: Complex alternative splicing: alternative splicing in the postgenomic Era. In Advances in Experimental Medicine and Biology, Volume 623. Edited by Blencowe BJ, Graveley BR. New York: LANDES Bioscience; 2007:50-63.
• [5]Coutinho-Mansfield GC, Xue Y, Zhang Y, Fu XD: PTB/nPTB switch: a post-transcriptional mechanism for programming neuronal differentiation. Genes Dev 2007, 21:1573-1577.
• [6]Ule J, Stefani G, Mele A, Ruggiu M, Wang X, Taneri B, Gaasterland T, Blencowe BJ, Darnell RB: An RNA map predicting Nova-dependent splicing regulation. Nature 2006, 444:580-586.
• [7]Zhang C, Zhang Z, Castle J, Sun S, Johnson J, Krainer AR, Zhang MQ: Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev 2008, 22:2550-2563.
• [8]Black DL: Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003, 72:291-336.
• [9]Matlin AJ, Clark F, Smith CW: Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol 2005, 6:386-398.
• [10]Hallegger M, Llorian M, Smith CW: Alternative splicing: global insights. FEBS J 2010, 277:856-866.
• [11]Weyn-Vanhentenryck SM, Mele A, Yan Q, Sun S, Farny N, Zhang Z, Xue C, Herre M, Silver PA, Zhang MQ, Krainer AR, Darnell RB, Zhang C: HITS-CLIP and integrative modeling define the rbfox splicing-regulatory network linked to brain development and autism. Cell Rep 2014, 6:1139-1152.
• [12]Suzuki H, Osaki K, Sano K, Alam AH, Nakamura Y, Ishigaki Y, Kawahara K, Tsukahara T: Comprehensive analysis of alternative splicing and functionality in neuronal differentiation of P19 cells. PLoS One 2011, 6:e16880. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0016880 webcite
• [13]Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH: Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
• [14]Reddy PP, Raghuram V, Hradsky J, Spilker C, Chakraborty A, Sharma Y, Mikhaylova M, Kreutz MR: Molecular dynamics of the neuronal EF-hand Ca2+-sensor Caldendrin. PLoS One 2014, 9:e103186.
• [15]Soni S, Tyagi C, Grover A, Goswami SK: Molecular modeling and molecular dynamics simulations based structural analysis of the SG2NA protein variants. BMC Res Notes 2014, 7:446. BioMed Central Full Text
• [16]Barbany M, Morata J, Meyer T, Lois S, Orozco M, de la Cruz X: Characterization of the impact of alternative splicing on protein dynamics: the cases of glutathione S-transferase and ectodysplasin-a isoforms. Proteins 2012, 80:2235-2249.
• [17]Rajendran V, Purohit R, Sethumadhavan R: In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Amino Acids 2012, 43:603-615.
• [18]Suzuki H, Takeuchi M, Sugiyama A, Alam AH, Vu LT, Sekiyama Y, Dam HC, Ohki SY, Tsukahara T: Alternative splicing produces structural and functional changes in CUGBP2. BMC Biochem 2012, 13:6. BioMed Central Full Text
• [19]Chang TY, Li YY, Jen CH, Yang TP, Lin CH, Hsu MT, Wang HW: easyExon—a Java-based GUI tool for processing and visualization of Affymetrix exon array data. BMC Bioinforma 2008, 9:432. BioMed Central Full Text
• [20]Xing Y, Stoilov P, Kapur K, Han A, Jiang H, Shen S, Black DL, Wong WH: MADS: a new and improved method for analysis of differential alternative splicing by exon-tiling microarrays. RNA 2008, 14:1470-1479.
• [21]Yates T, Okoniewski MJ, Miller CJ: X:Map: annotation and visualization of genome structure for affymetrix exon array analysis. Nucleic Acids Res 2008, 36:D780-D786.
• [22]Purdom E, Simpson KM, Robinson MD, Conboy JG, Lapuk AV, Speed TP: FIRMA: a method for detection of alternative splicing from exon array data. Bioinformatics 2008, 24:1707-1714.
• [23]Emig D, Salomonis N, Baumbach J, Lengauer T, Conklin BR, Albrecht M: AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res. 2010, Web Server issue:W755-W762.
• [24]Wullschleger S, Loewith R, Hall MN: TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
• [25]Magri L, Galli R: mTOR signaling in neural stem cells: from basic biology to disease. Cell Mol Life Sci 2013, 70:2887-2898.
• [26]Kuhn RM, Karolchik D, Zweig AS, Wang T, Smith KE, Rosenbloom KR, Rhead B, Raney BJ, Pohl A, Pheasant M, Meyer L, Hsu F, Hinrichs AS, Harte RA, Giardine B, Fujita P, Diekhans M, Dreszer T, Clawson H, Barber GP, Haussler D, Kent WJ: The UCSC genome browser database: update 2009. Nucleic Acids Res 2009, 37(Database issue):D755-D761.
• [27]Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Lu F, Marchler GH, Mullokandov M, Omelchenko MV, Robertson CL, Song JS, Thanki N, Yamashita RA, Zhang D, Zhang N, Zheng C, Bryant SH: CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res 2011, 39(Database issue):D225-D229.
• [28]Nikitin A, Egorov S, Daraselia N, Mazo I: Pathway studio–the analysis and navigation of molecular networks. Bioinformatics 2003, 19:2155-2157.
• [29]Novichkova S, Egorov S, Daraselia N: MedScan, a natural language processing engine for MEDLINE abstracts. Bioinformatics 2003, 19:1699-1706.
• [30]Yoon HY, Kales SC, Luo R, Lipkowitz S, Randazzo PA: ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. Biol Cell 2011, 103:171-184.
• [31]Flinterman MB, Mymryk JS, Klanrit P, Yousef AF, Lowe SW, Caldas C, Gäken J, Farzaneh F, Tavassoli M: p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing. Oncogene 2007, 26:6863-6874.
• [32]Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P: Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem 2006, 281:14026-14040.
• [33]Jones-Villeneuve EM, McBurney MW, Rogers KA, Kalnins VI: Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol 1982, 94:253-262.
• [34]Hakim NH, Kounish T, Alam AHMK, Tsukahara T, Suzuki H: Alternative splicing of Mef2c promoted by Fox-1 during neural differentiation in P19 cells. Genes Cells 2010, 15:255-267.
• [35]Sharma SV, Bell DW, Settleman J, Haber DA: Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007, 7:169-181.
• [36]Huot MÉ, Vogel G, Zabarauskas A, Ngo CT, Coulombe-Huntington J, Majewski J, Richard S: The Sam68 STAR RNA-binding protein regulates mTOR alternative splicing during adipogenesis. Mol Cell 2012, 46:187-199.
• [37]Ostrakhovitch EA, Semenikhin OA: p53-mediated regulation of neuronal differentiation via regulation of dual oxidase maturation factor 1. Neurosci Lett 2011, 494:80-85.
• [38]Jozwiak J, Jozwiak S, Grzela T, Lazarczyk M: Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway. Neuromol Med 2005, 7:287-296.
• [39]Emamian ES: AKT/GSK3 signaling pathway and schizophrenia. Front Mol Neurosci 2012, 5:33.
• [40]Alam AH, Suzuki H, Tsukahara T: Retinoic acid treatment and cell aggregation independently regulate alternative splicing in P19 cells during neural differentiation. Cell Biol Int 2010, 34:631-643.
• [41]Alam AH, Suzuki H, Tsukahara T: Expression analysis of Fgf8a &Fgf8b in early stage of P19 cells during neural differentiation. Cell Biol Int 2009, 33:1032-1037.